Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Tswelopele hosts first LGBTQI panel discussion
2016-10-05

Description: LGBTQI  Tags: LGBTQI

Tshepang Mahlatsi, Zane Thela, Dionne van
Reenen, Dr Thierry Luescher and Galeletsang
Soato, at the Brotherhood with no Limit panel
discussion held at Tswelopele residence on
the Bloemfontein Campus.
Photo: Supplied

Ignorance about issues relating to the Lesbian, Gay, Bisexual, Transgender, Queer and Intersex (LGBTQI) community is a threat to mankind. This is according to Tshepang Mahlatsi, former Prime of Tswelopele residence, regarding LGBTQI concerns at University of the Free State (UFS).

House Tswelopele on the Bloemfontein Campus hosted a panel discussion, Brotherhood with no Limit, on 19 September 2016 to discuss issues affecting the LGBTQI community, which has often been on the receiving end of criticism, hate speech and bigotry.

Academics take stance at LGBTQI discussion

The panel, which consisted of staff members and students, opened the discussion to everyone on campus. The panel comprised Zane Thela, Programme Coordinator: Gender and Sexual Equity Office: Student Affairs; Dionne van Reenen, Assistant Researcher; Dr Thierry Luescher, Assistant Director, Directorate for Institutional Research and Academic Planning, and Mahlatsi.

Creating a safer environment for LQBTQI dialogue

“The message that we were putting across was simple. We as a house cannot allow society to define our own brothers for us,” Mahlatsi said. The responsibility of students and student leaders was to stand in solidarity. He said it was not fair that in the 21st century people were still fighting to be recognised for who they were and what they identified themselves as. This issue had been discussed at Tswelopele before and it was not that much of an issue, Mahlatsi said. “However, this was the first formal one [discussion] where we had speakers who are more informed on the topic.”

The panel discussion also aimed to challenge other residences that still do not allow such talks to take place in a safe environment.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept